CYT003-QbG10
Drug6 subcutaneous injections
NCT Number: NCT00575003
The purpose of the study is to test the efficacy of a vaccine against house dust mite and/or cat allergy compared to placebo in adult patients.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 2
Tartu University Clinic, Lungs Clinic, Tartu, Estonia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6 subcutaneous injections
Time frame: on 4 occations over 1 year
Time frame: at each visit
Cytos Biotechnology AG
Industry
Double-Blind, Placebo-Controlled Study to Investigate an Immunomodulatory Therapy (CYT003-QbG10) in Adult Patients With Perennial Allergic Rhinoconjunctivitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.